drugset / Trial / NCT01293747
Pharmacokinetics of Injectable Estradiol and Progesterone Microspheres Suspension
RandomizedParallel-groupOpen-labelTreatment
Summary
Phase I pharmacokinetic study Main objective: To determine plasmatic profiles and pharmacokinetic parameters of estradiol and progesterone on each of the formulations studied, after multiple-dose administration Study design: Randomized, controlled, open-label, parallel, pharmacokinetic study Sites: 1 Subjects: 30 postmenopausal women
Timeline
- Start
- 2011-02
- Primary completion
- 2011-08
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Estradiol | Other / unclassified | 0.5 mg | Intramuscular |
| Subject | Estradiol | Other / unclassified | 1 mg | Intramuscular |
| Subject | Progesterone | Other / unclassified | 15 mg | Intramuscular |
| Subject | Progesterone | Other / unclassified | 20 mg | Intramuscular |
Indications
No indication recorded.